Gallop Oncology

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

6 Tide St, Boston, Massachusetts, 02210,...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Gallop Oncology

Gallop Oncology is a clinical-stage biopharma company focused on developing innovative drugs that target galectin-9, a key regulator in cancer processes. Their lead asset, LYT-200, is designed to treat hematologic malignancies such as acute myeloid leukemia and solid tumors like head and neck cancers, utilizing a dual mechanism of direct tumor suppression and immune modulation. The company aims to transform treatment paradigms and improve patient outcomes by addressing critical unmet needs in oncology. With Fast Track and Orphan Drug Designations from the FDA, Gallop Oncology is committed to advancing its clinical trials and delivering effective therapies.Explore more
Popular SearchesGallop OncologySIC Code 28,283NAICS Code 32,325Show more

Gallop Oncology Org Chart

PhoneEmail
TM
United States flag for contact location.

Manager, Clinical Trial

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Gallop Oncology your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Gallop Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Gallop Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gallop Oncology.

Top Manufacturing Companies

Frequently Asked Questions Regarding Gallop Oncology

What is Gallop Oncology's official website?
Gallop Oncology's official website is www.galloponcology.com
What is Gallop Oncology's Revenue?
Gallop Oncology's revenue is <$5 Million
What is Gallop Oncology's SIC code?
Gallop Oncology's SIC: 28,283
What is Gallop Oncology's NAICS code?
Gallop Oncology's NAICS: 32,325
How many employees does Gallop Oncology have?
Gallop Oncology has 11-50 employees
What industry does Gallop Oncology belong to?
Gallop Oncology is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What does Gallop Oncology do?

Gallop Oncology is a clinical-stage biopharma company focused on developing innovative drugs that target galectin-9, a key regulator in cancer processes. Their lead asset, LYT-200, is designed to treat hematologic malignancies such as acute myeloid leukemia and solid tumors like head and neck cancers, utilizing a dual mechanism of direct tumor supp... ression and immune modulation. The company aims to transform treatment paradigms and improve patient outcomes by addressing critical unmet needs in oncology. With Fast Track and Orphan Drug Designations from the FDA, Gallop Oncology is committed to advancing its clinical trials and delivering effective therapies.Read More

Is Gallop Oncology a public company?
Gallop Oncology is private company therefore does not currently have an official ticker symbol
See more information about Gallop Oncology

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.